Viewing Study NCT00813332

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:49 PM
Ignite Modification Date: 2026-05-29 @ 11:55 AM
Study NCT ID: NCT00813332
Status: UNKNOWN
Last Update Posted: 2010-01-25
First Post: 2008-12-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC)
Sponsor: Simcere Pharmaceutical Co., Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced NSCLC View
None Recurrent NSCLC View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Endostar View
None NSCLC View
None Docetaxel View
None Combined therapy View
None second-line chemotherapy View